Increased Circulating Matrix Metalloproteinase-2 in Patients With Hypertrophic Cardiomyopathy With Systolic Dysfunction
Authors:
Open Access
- 1 January 2004
- journal article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 68 (4) , 355-360
Abstract
Background Some patients with hypertrophic cardiomyopathy (HCM) develop left ventricular (LV) wall thinning associated with LV dilatation and systolic dysfunction. Recently, matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) were reported to be involved in ventricular remodeling, however, little is known about MMPs and TIMPs in patients with HCM. Methods and Results Enzyme-linked immunoassays were used to measure the plasma concentrations of MMP-2, MMP-3, MMP-9, TIMP-1, and TIMP-2 in 11 patients with HCM accompanied by systolic dysfunction (fractional shortening (FS) <25%, group A), 17 patients with HCM who had preserved systolic function (FS ≥25%, group B), and 50 age-matched clinically healthy control subjects (mean age: 57 years). The concentration of MMP-2 in group A was significantly higher than in group B and the control subjects (1,124±84, 792±49, 809±26 ng/ml, respectively), whereas there was no significant difference between group B and the control subjects. MMP-2 concentrations significantly increased as the New York Heart Association functional class increased in patients with HCM. TIMP-2 was also significantly higher in group A patients than in group B and the control subjects (45.3±4.7, 34.6±2.2, 33.7±1.8 ng/ml, respectively), but there was no difference between group B and control subjects. TIMP-1 was significantly higher in HCM patients than in control subjects. MMP-3 and MMP-9 concentrations did not differ among the 3 groups. Both MMP-2 and TIMP-2 correlated significantly with FS and LV dimension, negatively and positively, respectively. Conclusions These results suggest that changes in the release and activity of MMP-2 and TIMP-2 may be associated with the mechanisms responsible for cardiac remodeling in patients with HCM. (Circ J 2004; 68: 355 - 360)Keywords
This publication has 41 references indexed in Scilit:
- Epidemiologic and Clinical Characteristics of Cardiomyopathies in Japan. Results From Nationwide Surveys.Circulation Journal, 2002
- EditorialThe American Journal of Cardiology, 1998
- Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis CJournal of Hepatology, 1997
- Tumor invasion, proteolysis, and angiogenesisJournal of Neuro-Oncology, 1994
- An autopsy case of hypertrophic cardiomyopathy showing dilated cardiomyopathy-like features by serial ventriculography.Japanese Journal of Medicine, 1990
- Inadequate collagen tethers in dilated cardiopathyAmerican Heart Journal, 1988
- Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1987
- Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathyAmerican Heart Journal, 1985
- Hypertrophie cardiomyopathy: A discussion of nomenclatureThe American Journal of Cardiology, 1979
- Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathyAmerican Heart Journal, 1979